Apr 15, 2022|
JD Health Launches World’s First Diagnostic Kit for Methylated Genes of Lung Cancer
by Vivian Yang
JD Health announced on April 15th that it became the first online retailer to offer sales of the world’s first diagnostic kit for methylated genes of lung cancer to Chinese consumers.
The kit, also known as “Ai Fei Ming” (艾肺明), developed by Excellen Medical Technology Co., Ltd, a Beijing-based company specializing in cancer diagnostics, provides a blood-based test for the diagnosis of lung cancer that consumers can now easily order via JD Health’s online channel and enjoy convenient offline services.
Consumers can either make blood sampling appointments- merely 5ml of blood with LDCT cancer screening result of 86.83% sensitivity and 95.59% specificity – at home or go to designated nearby clinics. They will receive test reports on their mobile phones and follow-up medical advice in around a week’s time to be well-informed of their health status.
The service product is packaged as a gift box primarily for parents, with a test invitation card available on JD Health’s product page.
According to China’s National Cancer Center’s latest report released in February 2022 based on statistics from 2016, lung cancer topped the list both in terms of morbidity and mortality, with around 820,000 new cases and 710,000 deaths in one year, making up 23.8% of the overall deaths of all cancers.
Early diagnosis means a much greater chance of survival from lung cancer. It is also an essential area where JD Health can leverage its advantages and partners to build a one-stop solution for users which includes the provision of self-test kits, test reports analysis, offline health check and clinic appointments, online healthcare consultations and more.
During this year’s Anti-Cancer Week, JD Health will also join hands with the China Anti-Cancer Association to introduce an array of promotional activities to raise people’s awareness of cancer prevention and relevant solutions.
Dec 12, 2024|
JD Health Debuts Merck’s New Diabetes Medication GLUCOPHAGE® XR (Reduce Mass) Online in China
On December 10, JD Health, in collaboration with Merck, a globally renowned biopharmaceutical leader, began offering GLUCOPHAGE® XR (Reduce Mass), the metformin hydrochloride extended-release tablets, and became the first online pharmacy in China to provide the new antidiabetic medication developed by Merck. This launch signifies a major milestone in the partnership between JD Health and Merck, which is dedicated to enhancing the online availability and accessibility of innovative treatments for type 2 diabetes patients in China, thereby offering them a more convenient and effective medication experience.
GLUCOPHAGE® has been a cornerstone in the treatment of type 2 diabetes for over 60 years worldwide. The latest version of this medication is designed to enhance patient adherence by reducing the long-term burden of medication administration while maintaining its therapeutic benefits. The use of GSD sustained-release technology extends the time the medication remains in the stomach, reduces gastrointestinal irritation, and improves drug absorption. Additionally, the tablet is now smaller, has reduced volume by 30%, and has been transitioned from a capsule to a round shape, making it easier to swallow. It requires only once-daily administration, significantly enhancing patient convenience and safety.
To celebrate the online launch collaboration, JD Health and Merck hosted a special release event for the new medication at the 7th China International Import Expo in November. This event followed their partnership agreement in September, which also marked the opening of Merck China’s self-operated flagship store on JD.com.
With a large user base, robust supply chain, and rich medical service resources, JD Health has become a preferred partner to launch many chronic disease medications online. By seamlessly integrating online and offline resources, JD Health ensures that new drug information reaches the right users swiftly, offering convenient purchasing options and improving drug accessibility and usage efficiency. Additionally, JD Health’s extensive logistics network ensures timely and secure delivery of medications, enhancing user experience and building trust.
(vivian.yang@jd.com)
Dec 3, 2024|
JD Foundation Advances Disability Support Initiatives in Strategic Partnership
On November 29, in celebration of the 33rd International Day of Persons with Disabilities, JD Foundation, in collaboration with the Beijing Disabled Persons’ Federation and the Beijing Disabled Persons’ Welfare Foundation, hosted a series of charitable events at JD.com’s headquarters. JD Foundation and the Beijing Disabled Persons’ Welfare Foundation have established a strategic partnership focused on improving the quality of life for people with disabilities, promoting their integration into society, exploring new philanthropic models, and creating awareness for public welfare institutions. These efforts are collectively aimed at achieving high-quality development in disability support services.
JD.com has a longstanding commitment to supporting individuals with disabilities since its inception. As early as 2005, when JD.com entered the e-commerce sector, the company has employed individuals with disabilities. Over the years, the company has expanded its efforts through skills training and empowerment initiatives, facilitating employment and entrepreneurship opportunities for individuals with disabilities. In October of 2013, JD Customer Service launched the “Sunshine Angels” project, through which hundreds of individuals with disabilities have been employed, with plans to offer part-time positions to 1,000 more. JD.com currently employs over 4,000 individuals with disabilities, a number that continues to grow.
The November 29 event featured a charity bazaar with handicrafts created by people with disabilities. The well-attended bazaar showcased a variety of unique items, including crocheted wool flowers, ornaments, enamelware, bracelets, Beijing silk figurines, children’s paintings, paper cuttings, and postcards. Proceeds from the sales will go toward disability-related charitable causes. JD employees who made purchases each received a certificate and a commemorative badge recognizing their support and participation in disability advocacy.
One of the event’s highlights was a guide dog demonstration, where three guide dog users and their canine companions captured the attention of attendees. The guide dogs demonstrated their ability to assist their owners in navigating streets, avoiding obstacles, and ensuring safe travel. Guide dogs not only help visually impaired individuals to navigate and find destinations but also serve as protectors during emergencies. Beyond their practical assistance, these dogs are invaluable companions, providing emotional support to their owners.
The event also featured an inspiring performance by artists with disabilities from Beijing, Hebei, Tianjin, and other regions, in which they presented a rich tapestry of songs, dances, instrumental music, and storytelling. The performance provided a vibrant, heartwarming cultural showcase to attendees.
(vivian.yang@jd.com)
JD Cloud Releases Products to Promote Industrial Digital Intelligence
